HomeAbout

TL;DR CNBC


A second coronavirus vaccine developed in India is set to enter phase three clinical trial 'very, very soon' - TL;DR CNBC

A second coronavirus vaccine developed in India is set to enter phase three clinical trial 'very, very soon'

Publishing timestamp: 2021-01-06 02:47:06


Summary


Sentiment: NEGATIVE

Tickers: ZYDUSLIFE-IN

Keywords:

Source: https://www.cnbc.com/2021/01/05/covid-19-india-coronavirus-vaccine-candidate-from-cadila-healthcare.html


Developed by Leo Phan